NYSEAM:MTNB - Post by User
Post by
whytestockson Jun 24, 2024 1:30pm
19 Views
Post# 36103572
Matinas BioPharma Reports Successful Treatment of Patient wi
Matinas BioPharma Reports Successful Treatment of Patient wi Breaking News: $MTNB Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access ProgramBEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful...
MTNB - Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program